Aptorum Group Interview to Air on Bloomberg International on the RedChip Money Report
May 29 2020 - 8:00AM
Business Wire
Aptorum Group Limited (NASDAQ:APM), a biopharmaceutical company
focused on the development of novel therapeutics to address global
unmet medical needs, today announced an interview with its
President, Darren Lui, will air on The RedChip Money Report
television program. The interview will air Sunday, May 31, at 3
p.m. local time on Bloomberg International, available in 100+
million homes across Europe.
In the exclusive interview, Lui provides an overview of the
Company’s development pipeline and near-term commercialization
efforts.
To view the interview segment, please visit:
https://youtu.be/ihyvRfw9pWU
The interview will also air in the US on the Action Channel on
Sunday May 31 at 11 a.m. and on the Family Channel on June 3 at 6
p.m. and is available via live stream on American Business TV.
“The RedChip Money Report" delivers insightful commentary on
small-cap investing, interviews with Wall Street analysts,
financial book reviews, as well as featured interviews with
executives of public companies.
About Aptorum Group
Aptorum Group Limited (Nasdaq:APM) is a pharmaceutical company
dedicated to developing and commercializing novel therapeutics to
tackle unmet medical needs. Aptorum Group’s current drug pipeline
includes indications in orphan diseases, infectious diseases and
metabolic diseases, a number of which are targeted to enter
clinical trial phases in H2 2020. Aptorum Group is also launching a
women’s health supplement, Dioscorea Opposita Bioactive
Nutraceutical Tablets, which will be commercialized soon.
For more information about the Company, please visit
www.aptorumgroup.com.
Disclaimer and Forward-Looking Statements
This press release includes statements concerning Aptorum Group
Limited and its future expectations, plans and prospects that
constitute "forward-looking statements" within the meaning of the
Private Securities Litigation Reform Act of 1995. For this purpose,
any statements contained herein that are not statements of
historical fact may be deemed to be forward-looking statements. In
some cases, you can identify forward-looking statements by terms
such as "may," "should," "expects," "plans," "anticipates,"
"could," "intends," "target," "projects," "contemplates,"
"believes," "estimates," "predicts," "potential," or "continue," or
the negative of these terms or other similar expressions. Aptorum
Group has based these forward-looking statements, which include
statements regarding projected timelines for application
submissions and trials, largely on its current expectations and
projections about future events and trends that it believes may
affect its business, financial condition and results of operations.
These forward-looking statements speak only as of the date of this
press release and are subject to a number of risks, uncertainties
and assumptions including, without limitation, risks related to its
announced management and organizational changes, the continued
service and availability of key personnel, its ability to expand
its product assortments by offering additional products for
additional consumer segments, development results, the company’s
anticipated growth strategies, anticipated trends and challenges in
its business, and its expectations regarding, and the stability of,
its supply chain, and the risks more fully described in Aptorum
Group’s Form 20-F and other filings that Aptorum Group may make
with the SEC in the future. As a result, the projections included
in such forward-looking statements are subject to change and could
be materially different from those described herein. Aptorum Group
assumes no obligation to update any forward-looking statements
contained in this press release as a result of new information,
future events or otherwise.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200529005242/en/
Investor Relations: Tel: +852 3953 7700 Email:
investor.relations@aptorumgroup.com
U.S. Investor Relations RedChip Companies, Inc. Dave Gentry Tel:
(407) 491-4498
Media Tel: + 852 3953 7700 Email: info@aptorumgroup.com
Aptorum (NASDAQ:APM)
Historical Stock Chart
From Mar 2024 to Apr 2024
Aptorum (NASDAQ:APM)
Historical Stock Chart
From Apr 2023 to Apr 2024